Quartel Adrian W
- SEC CIK
- 0001910132
In the past year, 1 open-market sale filing worth $40.0K and no purchases.
Current role at each company
- SPRB Spruce Biosciences, Inc.Chief Medical Officeras of Jul 29, 2026
- ZVRA Zevra Therapeutics, Inc.Chief Medical Officeras of Feb 2, 2026
- ACER Acer Therapeutics Inc.Chief Medical Officeras of Mar 16, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $40.0K
- 1 filing
- Net
- −$40.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Quartel Adrian W as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ZVRA Zevra Therapeutics, Inc.
Chief Medical Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2026 (view filing) | Jan 30 | 3 days | Quartel Adrian WChief Medical Officer | SSale | −4.53K | $8.83 | −$40.0K | −31.8%9.72K after | 10b5-1 |